BSECompany Update2d ago · 23 Oct 2026, 05:22 pm
Schedule of Earnings Conference Call on Unaudited Financial Results for quarter ended September 30, 2026.
Rainbow Children's Medicare Ltd · 543524
✦ AI SummaryResults
Rainbow Children's Medicare Ltd has announced a schedule for an earnings conference call to discuss its unaudited financial results for the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
d9a8f93d-3925-44fd-8b7a-e84a139b656b.pdf
View document text
October 23, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, Plot No. C/1, G Block, Corporate Relationship Department,
Bandra Kurla Complex, Bandra (E), Phiroze Jeejeebhoy Towers,
Mumbai – 400 051. Dalal Street, Mumbai – 400001.
Symbol: RAINBOW Scrip Code: 543524
Sub: Intimation of Earnings Conference Call – Q2 & FY 2026-27.
Dear Sir/ Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure
Requirements) Regulations 2015, please find attached invite of the Earnings Conference
Call for Investors/ Analysts to be held on Monday, November 2, 2026 at 10:00 AM (IST) to
discuss the financial and operating performance for quarter ended September 30, 2026.
We request you to kindly take the same on record.
Thanking You,
Yours Faithfully,
For Rainbow Children’s Medicare Limited
Shreya Mitra
Company Secretary and Compliance Officer
Encl.: As above
Rainbow Children’s Medicare Ltd
Earnings Conference Call
Monday, 02nd Nov 2026, 10:00 am (IST)
IIFL is pleased to invite you to join a conference call with the management of Rainbow Children’s Medicare Ltd (RAINBOW IN) to
discuss the company’s business strategy and outlook post the declaration of its Q2FY27 financial results.
Dr. Ramesh Kancharla – Chairman and MD
Mr. Abrar Ali Dalal – Group Chief Executive Officer
Management participants
Mr. Sudarshan Patodia – Group Chief Financial Officer
Mr. Saurabh Bhandari – Head IR & Business Intelligence
Monday, 2nd Nov 2026, 10:00 am (IST)
Date / Time
(HK/Singapore – 12:30 pm, UK – 4:30 am, USA – 11:30 pm ET – 1st Nov)
Conference dial-in numbers
Pre-registration link Diamond Pass Registration
India
Primary Number +91 22 6280 1259 / +91 22 7115 8160
International Toll-free number
USA 1-866 746 2133
UK 0-808 101 1573
Singapore 800-101 2045
Hong Kong 800-964 448
For further information, please contact:
Rahul Jeewani | Tel: +91 22 4646 4673 | Email: rahul.jeewani@iiflcap.com
Naman Bagrecha | Tel: +91 22 4646 4718 | Email: naman.bagrecha@iiflcap.com
Aman Goyal | Tel: +91 22 4646 4705 | Email: aman.goyal@iiflcap.com
Vighnesh Indure | Tel: +91 22 4646 4661 | Email: vighnesh.indure@iiflcap.com
IIFL - 24th floor, One Lodha Place, Senapati Bapat Marg, Lower Parel (W), Mumbai 400 013, Tel: (91-22) 4646 4600, Fax: (91-22) 4646 4700